Aratana Therapeutics, a US developer of medicines for pets, sets IPO terms.

Researchers and Evotec and Harvard to collaborate on new class of antibiotics.

Drugmaker duo enters partnership with Atlas Venture.

Last month, peer Bina Technologies raised $6.25m, while Spiral Genetics gathered $3m from venture capital firm DFJ after forming from University of Washington entrepreneurship class in 2009, according to news provider Xconomy.

InSilico Genomics offers academics and industry the ability to compare their data on parts of the human genome with public datasets.

Elan is buying AOP Orphan Pharmaceuticals, which has a minority stake in Shield Therapeutics, a Switzerland-based specialty pharmaceutical company.

Venture capital firms Volcano Capital, Crocker Capital and Aphelion Capital co-led the deal, and were joined by peer Windy City.

Venture capital firms Volcano Capital, Crocker Capital and Aphelion Capital co-led the deal, and were joined by peer Windy City.